NASDAQ:GMDAQ Gamida Cell (GMDAQ) Stock Price, News & Analysis → What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (From Weiss Ratings) (Ad) Free GMDAQ Stock Alerts $0.02 +0.00 (+2.41%) (As of 05/24/2024) Add Compare Share Share Today's Range$0.0160▼$0.018350-Day Range N/A52-Week Range$0.01▼$2.51Volume332,700 shsAverage Volume307,815 shsMarket Capitalization$2.62 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsOptions ChainSEC FilingsTrendsStock AnalysisChartCompetitorsEarningsFinancialsOptions ChainSEC FilingsTrends Get Gamida Cell alerts: Email Address Ad Weiss RatingsWhat is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners”A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. About Gamida CellGamida Cell Ltd. is a biopharmaceutical company. It focuses on developing cell therapies to cure cancer and rare and serious hematologic diseases. The company's product pipeline consists of NiCord and NAM-NK which are in clinical stage. It operates primarily in the United States, the European Union and internationally. Gamida Cell Ltd. is headquartered in Jerusalem, Israel.Read More GMDAQ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GMDAQ Stock News HeadlinesMay 17, 2024 | finance.yahoo.comGamida Cell Ltd. (GMDAQ)May 12, 2024 | msn.comGamida Cell has a second chance to be an Israeli success storyMay 8, 2024 | seekingalpha.comGMDAQ Gamida Cell Ltd.April 10, 2024 | wsj.comGamida Cell Ltd.See More Headlines Receive GMDAQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gamida Cell and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/27/2024Today6/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:GMDAQ CUSIPN/A CIK1600847 Webwww.gamida-cell.com Phone617-892-9080FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.49) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-63,000,000.00 Net MarginsN/A Pretax Margin-2,317.95% Return on EquityN/A Return on Assets-60.18% Debt Debt-to-Equity Ratio213.14 Current Ratio0.35 Quick Ratio0.33 Sales & Book Value Annual Sales$1.78 million Price / Sales1.47 Cash FlowN/A Price / Cash FlowN/A Book Value($0.12) per share Price / Book-0.14Miscellaneous Outstanding Shares154,050,000Free Float143,699,000Market Cap$2.62 million OptionableOptionable Beta1.14 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key CompetitorsOrganovoNASDAQ:ONVOCoeptis TherapeuticsNASDAQ:COEPBioCardiaNASDAQ:BCDAGenetic TechnologiesNASDAQ:GENEChromocell TherapeuticsNYSE:CHROView All Competitors GMDAQ Stock Analysis - Frequently Asked Questions How have GMDAQ shares performed in 2024? Gamida Cell's stock was trading at $0.0151 at the start of the year. Since then, GMDAQ shares have increased by 12.6% and is now trading at $0.0170. View the best growth stocks for 2024 here. How were Gamida Cell's earnings last quarter? Gamida Cell Ltd. (NASDAQ:GMDAQ) announced its quarterly earnings results on Wednesday, March, 27th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.13) by $0.09. The company had revenue of $1.11 million for the quarter, compared to the consensus estimate of $1.21 million. How do I buy shares of Gamida Cell? Shares of GMDAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GMDAQ) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gamida Cell Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.